Intro

Europe: 2x United States; 3x China publi; Europe only 25 percent of new biotechs

Europe is a powerhouse in scientific publishing with roughly twice the output of the United States and three times that of China...Despite Europe’s strength in science and innovation, translation remains the biggest challenge. Translation of science into companies is stagnant. The distribution of newly funded biotechs remains unchanged across geographies over the last six years, and Europe accounts for only 25 percent of new biotechs. Future success will depend on improving the translation of research into new companies, raising more capital, and building entrepreneurial talent.”

McKinsey